Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections

Autor: Janet L Leasher, Tunde Peto, Jill E Keeffe, Nina Tahhan, Konrad Pesudovs, Rohit Varma, Hans Limburg, John H. Kempen, Aditi Das, Alain M. Bron, Jinan Saadine, Jost B. Jonas, Hugh R. Taylor, Rupert R A Bourne, Serge Resnikoff, David S Friedman, Tien Yin Wong, Seth Flaxman, Maria Vittoria Cicinelli, Kovin Naidoo, Alexander J Silvester
Přispěvatelé: Anglia Ruskin University (ARU), University Hospital Center Mannheim, Partenaires INRAE, Centre des Sciences du Goût et de l'Alimentation [Dijon] (CSGA), Centre National de la Recherche Scientifique (CNRS)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB), Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), San Raffaele Scientific Institute, Health Education Yorkshire and the Humber, Imperial College London, Wilmer Eye Institute, Johns Hopkins University School of Medicine, L V Prasad Eye Institute, Massachusetts Eye and Ear Infirmary, Medical Center, Nova Southeastern University (NSU), Health Information Services, University of KwaZulu-Natal (UKZN), NHMRC Centre for Clinical Eye Research, Dentistry and Biomedical Sciences, Centers for Disease Control and Prevention, Royal Liverpool University Hospital, La Vision, University of New South Wales [Sydney] (UNSW), Melbourne School of Population Health, Keck School of Medicine of USC, Singapore Eye Research Institute [Singapore] (SERI), National University of Singapore (NUS), Heidelberg University, Flinders University, University of Melbourne, Bourne, Rupert R. A., Bourne, Rra, Jonas, Jb, Bron, Am, Cicinelli, Mv, Das, A, Flaxman, Sr, Friedman, D, Keeffe, Je, Kempen, Jh, Leasher, J, Limburg, H, Naidoo, K, Pesudovs, K, Peto, T, Saadine, J, Silvester, Aj, Tahhan, N, Taylor, Hr, Varma, R, Wong, Ty, Resnikoff, S, on behalf of the Vision Loss Expert Group of the Global Burden of Disease, Study, Battaglia Parodi, M
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Refractive error
Organes des sens
genetic structures
Glaucoma
Ophthalmology & Optometry
Macular Degeneration
0302 clinical medicine
Epidemiology
030212 general & internal medicine
education.field_of_study
GLOBAL PREVALENCE
public health
DEGENERAÇÃO MACULAR
Diabetic retinopathy
Refractive Errors
Sensory Systems
3. Good health
Global Issues
Blindne
Europe
1117 Public Health And Health Services
BLINDNESS
épidémiologie
Female
INDIA
epidemiology
medicine.symptom
OPEN-ANGLE GLAUCOMA
Life Sciences & Biomedicine
Human
Developed Countrie
medicine.medical_specialty
Population
Visual impairment
Sensory Organs
Médecine humaine et pathologie
Cataract
03 medical and health sciences
Cellular and Molecular Neuroscience
SDG 3 - Good Health and Well-being
medicine
Journal Article
Humans
VISUAL IMPAIRMENT
[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs
education
Diabetic Retinopathy
Science & Technology
business.industry
Developed Countries
1103 Clinical Sciences
Presbyopia
Macular degeneration
Vision Loss Expert Group of the Global Burden of Disease Study
medicine.disease
MACULAR DEGENERATION
RANIBIZUMAB
1113 Ophthalmology And Optometry
eye diseases
Ophthalmology
glaucoma
santé publique
glaucome
DISTANCE
030221 ophthalmology & optometry
Human health and pathology
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Demography
Zdroj: British Journal of Ophthalmology
British Journal of Ophthalmology, BMJ Publishing Group, 2018, 102 (5), pp.575-585. ⟨10.1136/bjophthalmol-2017-311258⟩
British Journal of Ophthalmology 5 (102), 575-585. (2018)
Bourne, R R A, Jonas, J B, Bron, A M, Cicinelli, M V, Das, A, Flaxman, S R, Friedman, D S, Keeffe, J E, Kempen, J H, Leasher, J, Limburg, H, Naidoo, K, Pesudovs, K, Peto, T, Saadine, J, Silvester, A J, Tahhan, N, Taylor, H R, Varma, R, Wong, T Y, Resnikoff, S & Vision Loss Expert Group of the Global Burden of Disease Study 2018, ' Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections ', British Journal of Ophthalmology . https://doi.org/10.1136/bjophthalmol-2017-311258
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
The British Journal of Ophthalmology
ISSN: 0007-1161
1468-2079
Popis: BackgroundWithin a surveillance of the prevalence and causes of vision impairment in high-income regions and Central/Eastern Europe, we update figures through 2015 and forecast expected values in 2020.MethodsBased on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment and presbyopia was estimated for 1990, 2010, 2015, and 2020.ResultsAge-standardised prevalence of blindness and MSVI for all ages decreased from 1990 to 2015 from 0.26% (0.10–0.46) to 0.15% (0.06–0.26) and from 1.74% (0.76–2.94) to 1.27% (0.55–2.17), respectively. In 2015, the number of individuals affected by blindness, MSVI and mild vision impairment ranged from 70 000, 630 000 and 610 000, respectively, in Australasia to 980 000, 7.46 million and 7.25 million, respectively, in North America and 1.16 million, 9.61 million and 9.47 million, respectively, in Western Europe. In 2015, cataract was the most common cause for blindness, followed by age-related macular degeneration (AMD), glaucoma, uncorrected refractive error, diabetic retinopathy and cornea-related disorders, with declining burden from cataract and AMD over time. Uncorrected refractive error was the leading cause of MSVI.ConclusionsWhile continuing to advance control of cataract and AMD as the leading causes of blindness remains a high priority, overcoming barriers to uptake of refractive error services would address approximately half of the MSVI burden. New data on burden of presbyopia identify this entity as an important public health problem in this population. Additional research on better treatments, better implementation with existing tools and ongoing surveillance of the problem is needed.
Databáze: OpenAIRE